from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0564c/gpdA1

LFCtreatmentdescriptionclass of inhibitor

-0.347

Amikacinug/mL Amikacintranslation

0.267

Cap5-10ug/mL Capreomycintranslation

1.033

Rox10-50 ug/mL Roxithromycintranslation

0.170

SM2-5 ug/mL Streptomycintranslation

-0.070

Tet5-10 ug/mL Tetracyclinetranslation

1.304

Rif0.2-5ug/mL Rifampicintranscription

0.313

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.148

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.081

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.141

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.041

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.251

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-3.600

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.722

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.103

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.641

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.842

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.502

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.274

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.067

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-2.675

KCN5-20 ug/mL Potassium cyaniderespiration

0.119

NaN30.2-2 mM Sodium aziderespiration

0.528

Nigericin50 uM Nigericinrespiration

-0.054

TRC10-150 ug/mL Triclosanrespiration

-1.163

TRZ10-25 ug/mL Thioridazinerespiration

-1.113

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.340

menadione6-10 ug/mL Menadionerespiration

0.531

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.151

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.416

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.208

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.972

NRP_1Non-replicating persistence stage 1dosRassociated

-0.216

Amp0.2mg/mL AmpicillincellWall

-0.707

Cephalexin20-100 ug/mL CephalexincellWall

0.088

Cerulenin0.32-5 ug/mL CerulenincellWall

0.197

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.173

EMB10-20 ug/mL EthambutolcellWall

-0.038

Eta12-40 ug/mL EthionamidecellWall

-0.394

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.115

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.055

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.542

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.080

BZA0.12 mg/mL BenzamidearomaticAmides

0.662

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.388

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.405

H2O24 mM hydrogen peroxideDNAdamaging

1.135

Levo10 ug/mL LevofloxacinDNAdamaging

0.293

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.960

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.948

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.972

UVUV-irradiationDNAdamaging

-0.993

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.143

Antimycin12.5-50 ug/mL Antimycin A?

-0.573

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.104

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.195

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.367

PA8240.2-2 ug/mL PA-824?

-0.719

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.378

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.275

Verapamil50 uM Verapamil?

-0.128

mercaptoethanol2 mM 2-Mercaptoethanol?

0.553

methoxatin10-20 ug/mL Methoxatin?